
Singer's Elliott Battles Texas Private Equity Firm Over Fees
In a court case in Delaware, Elliott is seeking documents it says could show that Stronghold Investment Management, a Texas private equity firm, billed tens of millions of dollars in excess expenses. A judge is now weighing whether to force Stronghold to turn over internal records about how it charged Elliott for managing about $100 million in oil and gas bets.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
13 minutes ago
- Yahoo
Jeeva.ai Launches Jeeva 2.0, Empowering GTM Teams with Agentic AI for 10x Sales Productivity
SAN FRANCISCO, July 21, 2025--(BUSINESS WIRE)-- a cutting-edge AI-driven sales automation platform, today announced the launch of Jeeva 2.0, marking a major milestone as it opens its powerful autonomous sales assistant capabilities to every member of the go-to-market (GTM) team. This Product-Led Growth (PLG) launch on Product Hunt aims to revolutionize how sales professionals operate by delivering AI-powered tools designed to amplify productivity, precision, and personalization. Dubbed the "Cursor/Codex for sales reps," Jeeva 2.0 blends advanced AI with deep sales expertise to automate repetitive and time-consuming tasks, giving reps more time to focus on high-impact conversations and closing deals. Key new features include: Auto Email Drafting & Inbox Labeling: Personalization at ScaleJeeva 2.0 streamlines email outreach by auto-drafting personalized messages based on past interactions and customer data, saving reps hours weekly while preserving their authentic voice. Its inbox labeling feature organizes incoming emails automatically, helping reps prioritize and respond efficiently. Automated Meeting Notes: Stay PresentAutomatic note-taking captures key points in real time, letting reps focus fully on conversations without missing important details. AI-Powered Calendar: Simplify SchedulingThe AI calendar helps coordinate meetings, optimize schedules, and prevent conflicts—making time management effortless. Meeting Preparation Assistance: Arrive ReadyBefore meetings, Jeeva 2.0 surfaces relevant insights about prospects and past interactions so reps can engage confidently. "Jeeva 2.0 is designed to empower every GTM team member, not just sales leaders, to become 10x more productive and effective," said Gaurav Bhattacharya, CEO of "By automating the grunt work and enabling truly personalized outreach and research at scale, we help teams unlock pipeline growth and revenue acceleration like never before." The launch on Product Hunt on July 21 will feature live demos, user stories, and a showcase of Jeeva's new autonomous AI assistants. invites GTM professionals worldwide to experience the future of sales automation and join the growing community transforming sales with AI. About Jeeva Jeeva is an agentic AI sales platform that automates prospect discovery, data enrichment, personalized outreach, and post-call follow-up in a single workflow. Drawing on live intent signals and self-directed processes, it surfaces high-fit leads, fills data gaps with accurate firmographic and contact information, drafts context-aware emails, and captures meeting notes—allowing sales teams to concentrate on relationships and revenue. Companies from seed-stage startups to large enterprises rely on Jeeva to expand pipeline and shorten sales cycles without adding headcount. Founded by serial entrepreneur Gaurav Bhattacharya, Jeeva operates globally. View source version on Contacts Address: 2708 Wilshire Blvd, #321, Santa Monica, CA 90403Gaurav Bhattacharya, CEO, Email - g@ Phone - 4246457525 Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
13 minutes ago
- Yahoo
UK Penny Stock Highlights: Diaceutics And 2 Compelling Options
The UK market has recently faced challenges, with the FTSE 100 index experiencing declines due to weak trade data from China, highlighting global economic interdependencies. For investors exploring opportunities beyond established names, penny stocks—typically smaller or newer companies—can offer intriguing prospects despite their somewhat outdated moniker. These stocks may present surprising value and potential stability when backed by solid financial health; in this article, we examine three such penny stocks that could offer compelling investment opportunities. Top 10 Penny Stocks In The United Kingdom Name Share Price Market Cap Financial Health Rating FRP Advisory Group (AIM:FRP) £1.215 £301.38M ★★★★★☆ Foresight Group Holdings (LSE:FSG) £4.535 £508.81M ★★★★★★ Warpaint London (AIM:W7L) £4.30 £347.39M ★★★★★★ Van Elle Holdings (AIM:VANL) £0.395 £42.74M ★★★★★★ System1 Group (AIM:SYS1) £4.25 £53.93M ★★★★★★ LSL Property Services (LSE:LSL) £3.04 £313.01M ★★★★★☆ Begbies Traynor Group (AIM:BEG) £1.245 £198.48M ★★★★★★ Croma Security Solutions Group (AIM:CSSG) £0.82 £11.29M ★★★★★★ Braemar (LSE:BMS) £2.26 £69.82M ★★★★★★ ME Group International (LSE:MEGP) £2.17 £819.53M ★★★★★★ Click here to see the full list of 296 stocks from our UK Penny Stocks screener. Let's explore several standout options from the results in the screener. Diaceutics Simply Wall St Financial Health Rating: ★★★★★☆ Overview: Diaceutics PLC is a diagnostic commercialization company that offers data, data analytics, and implementation services to pharmaceutical and biotech companies, with a market cap of £108.64 million. Operations: The company generates revenue from its Medical Labs & Research segment, totaling £32.16 million. Market Cap: £108.64M Diaceutics PLC, with a market cap of £108.64 million and revenue of £32.16 million, is navigating the challenges typical for smaller stocks in its sector. Despite being unprofitable, the company maintains a strong cash position with short-term assets exceeding liabilities and no debt burden. However, the board's limited experience and recent insider selling may raise concerns among investors. Analysts anticipate significant stock price appreciation, suggesting potential upside if growth forecasts materialize. The company's stable weekly volatility and absence of shareholder dilution over the past year provide some reassurance amidst its current financial struggles. Dive into the specifics of Diaceutics here with our thorough balance sheet health report. Review our growth performance report to gain insights into Diaceutics' future. Ashmore Group Simply Wall St Financial Health Rating: ★★★★★★ Overview: Ashmore Group plc is a publicly owned investment manager with a market cap of £1.13 billion. Operations: Ashmore Group does not report specific revenue segments. Market Cap: £1.13B Ashmore Group plc, with a market cap of £1.13 billion, presents a mixed picture for investors interested in penny stocks. Despite being debt-free and having short-term assets significantly exceeding liabilities, the company's earnings have declined by 25.1% annually over the past five years and are forecast to decline further. Recent board changes, including Anna Sweeney's appointment as Chair of the Audit and Risk Committee, may enhance governance but do not offset concerns about negative earnings growth and significant insider selling in recent months. The dividend yield is high at 9.84%, though not well covered by earnings or cash flows. Get an in-depth perspective on Ashmore Group's performance by reading our balance sheet health report here. Examine Ashmore Group's earnings growth report to understand how analysts expect it to perform. Watches of Switzerland Group Simply Wall St Financial Health Rating: ★★★★★☆ Overview: Watches of Switzerland Group PLC is a retailer specializing in luxury watches and jewelry across the United Kingdom, Europe, and the United States, with a market cap of £863.05 million. Operations: The company's revenue is derived from two main geographical segments: £785.60 million from the US and £865.90 million from the UK & Europe. Market Cap: £863.05M Watches of Switzerland Group, with a market cap of £863.05 million, offers potential for penny stock investors despite some challenges. The company reported full-year sales of £1.65 billion but experienced a decline in net income to £53.8 million due to a significant one-off loss of £57.9 million. While earnings growth was negative last year, the company has demonstrated consistent profit growth over five years and forecasts suggest earnings could grow by 20.94% annually moving forward. Its debt levels are well managed, with operating cash flow covering 95.3% of its debt, though short-term assets fall slightly short in covering long-term liabilities. Navigate through the intricacies of Watches of Switzerland Group with our comprehensive balance sheet health report here. Evaluate Watches of Switzerland Group's prospects by accessing our earnings growth report. Seize The Opportunity Jump into our full catalog of 296 UK Penny Stocks here. Seeking Other Investments? Rare earth metals are an input to most high-tech devices, military and defence systems and electric vehicles. The global race is on to secure supply of these critical minerals. Beat the pack to uncover the 26 best rare earth metal stocks of the very few that mine this essential strategic resource. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include AIM:DXRX LSE:ASHM and LSE:WOSG. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data


Bloomberg
16 minutes ago
- Bloomberg
Wise Co-Founder Slams Fintech's Plans to Move Listing to US
An investment vehicle owned by the co-founder of Wise Plc urged fellow shareholders to vote against the company shifting its primary listing out of London, arguing the move lacks transparency about important changes to governance. A vote for changing the listing location also requires shareholders to approve extending the dual-class shareholder structure that was introduced during the company's 2021 direct listing, according to a letter to shareholders from Skaala Investments OÜ. Skaala is controlled by Taavet Hinrikus, who left Wise in 2021 and has gone on to back many smaller stage technology firms.